RSS   Newsletter   Contact   Advertise with us

Dimension Therapeutics elects George Migausky to board

Staff writer | Cambridge, Mass., USA | June 11, 2015
Dimension TherapeuticsJune 11, 2015, Cambridge, Mass., USA - Dimension Therapeutics, a biotechnology company, announced the election of George Migausky to the company's board of directors.
Mr. Migausky brings more than 30 years of senior financial management experience with high-growth life science and technology companies. e will chair the newly established audit committee. Mr. Migausky is Executive Vice President and Chief Financial Officer of Dyax Corp.

Prior to joining Dyax, he served as the CFO of Wellstat Management Company, he held CFO positions at several public and private companies, including IGEN International, BioVeris Corporation, Hyperion Catalysis International, and ElectroScan Corporation.

At IGEN, Mr. Migausky was instrumental in preparing the company for its initial public offering in 1994, its merger with F. Hoffman La Roche in 2004, and the simultaneous spinoff of BioVeris Corporation as an independent public company.

In his senior manager functions, Mr. Migausky has been responsible for Sarbanes-Oxley compliance, public and private equity financings, and corporate partnering arrangements. He received an M.B.A. from Babson College and a B.S. from Boston College.


 LATEST MOVES FROM Massachusetts 


MORE INSIDE POST